The Exon Junction Complex component EIF4A3 plays a splicing-linked oncogenic role in pancreatic ductal adenocarcinomaRicardo Blázquez‐Encinas, Justo P. Castaño, Marina Sánchez‐Frías et al.|Cancer Gene Therapy|2024Cited by 6
The splicing machinery is dysregulated and represents a therapeutic vulnerability in breast cancerNatalia Hermán‐Sánchez, Manuel D. Gahete|Cellular and Molecular Life Sciences|2024Cited by 2
The Exon Junction Complex component EIF4A3 plays a splicing-linked oncogenic role in Pancreatic Ductal AdenocarcinomaRicardo Blázquez‐Encinas, Justo P. Castaño, Emilia Alors‐Pérez et al.|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 0